← Leaderboards
Timothy M Willson
University Of Cape Town
$15,713,013
Attributed
$19,188,120
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $79.7M · FY2020–25$100M$75M$50M$25M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$84,671,314 · 5
By mechanism
U19$78,243,444 · 2
R01$6,427,870 · 3
Top collaborators
- Kelly Chibale5 shared
- Lori Ferrins5 shared
- Alexander Tropsha5 shared
- Leah Elizabeth Cowen4 shared
- Ralph S Baric1 shared
Others in their field
Other Emerging Leaders on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Research focus
LeadStructureDrug CandidatePhosphotransferasesDrug DiscoveryAffinityLibrariesProteinsScreeningDrug ResistanceIn VivoCollaborationsDrug KineticsDesignMalariaToxic EffectInterestInfectionDrug TargetingDrug DevelopmentFutureStructural GenomicsInhibitorGenetic
Grant awards (16)
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis$617,457
R01 · FY2025 · AI
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis$618,537
R01 · FY2024 · AI
Enabling the Accelerated Discovery of Novel Chemical Probes by Integration of Crystallographic, Computational, and Synthetic Chemistry Approaches$548,908
R01 · FY2024 · GM
Repurposing kinase inhibitor chemotypes as antimalarials$279,425
R01 · FY2024 · AI
Administrative Supplement to: Enabling the Accelerated Discovery of Novel Chemical Probes by Integration of Crystallographic, Computational, and Synthetic Chemistry Approaches$166,986
R01 · FY2024 · GM
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis$621,777
R01 · FY2023 · AI
Enabling the Accelerated Discovery of Novel Chemical Probes by Integration of Crystallographic, Computational, and Synthetic Chemistry Approaches$549,024
R01 · FY2023 · GM
Repurposing kinase inhibitor chemotypes as antimalarials$290,699
R01 · FY2023 · AI
RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE- AViDD CENTER (READDI-AC)$65,483,194
U19 · FY2022 · AI
Core D: Medicinal Chemistry Core$12,760,250
U19 · FY2022 · AI · contact PI
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis$625,937
R01 · FY2022 · AI
Enabling the Accelerated Discovery of Novel Chemical Probes by Integration of Crystallographic, Computational, and Synthetic Chemistry Approaches$549,141
R01 · FY2022 · GM
Repurposing kinase inhibitor chemotypes as antimalarials$304,092
R01 · FY2022 · AI
Enabling the Accelerated Discovery of Novel Chemical Probes by Integration of Crystallographic, Computational, and Synthetic Chemistry Approaches$563,072
R01 · FY2021 · GM
Repurposing kinase inhibitor chemotypes as antimalarials$342,815
R01 · FY2021 · AI
Repurposing kinase inhibitor chemotypes as antimalarials$350,000
R01 · FY2020 · AI